Thank you to our speakers, sponsors, and delegates who joined us in Boston for the 4th Wet AMD & Diabetic Eye Disease Drug Development Summit! If you are interested in the 2025 event, please get in touch at info@hansonwade.com
Discovering Novel Retinal Vascular Models to Translate Neovascularization Targets Beyond Anti-VEGF into the Clinic
March 19 - 21, 2024 | Boston, MA
Accelerating Novel Retinal Vascular Target R&D into the Clinic
The 4ᵗʰ Wet AMD & Diabetic Eye Disease Drug Development Summit returned to Boston this March to unite 70+ industry-based retinal vascular experts from the likes of Bayer, Boehringer Ingelheim, Genentech, Novartis and OcuTerra, at the only industry-dedicated forum to transform the potential of treatment of chronic, sight-threatening retinal vascular diseases to improve patient outcomes.
Attendees joined the most comprehensive Wet AMD & Diabetic Eye Disease forum to:
- Hear data-driven case studies from industry experts from the likes of Bayer, Boehringer Ingelheim, Novartis and Genentech
- Participate with the interactive expert panel discussion navigating the current anti-VEGF treatment
- Meet and network with industry-based retinal vascular preclinical and clinical R&D scientists from Annexin Pharmaceuticals, OcuTerra Therapeutics, University of Southern California, Kodiak Sciences and more
18+ World-Class Pharma & Biotech Expert Speakers Included:
![](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2023/11/Screenshot-425-150x150.png)
![](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2024/03/Screenshot-75-150x150.png)
![](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2023/11/Screenshot-431-150x150.png)
![](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2024/02/Screenshot-509-150x150.png)
![](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2023/11/Screenshot-434-150x150.png)
![](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2023/11/Screenshot-437-150x150.png)
Past Companies in Attendance Included:
![previously attending companies previously attending companies](https://retinal-vascular-disease-summit.com/wp-content/uploads/sites/409/2022/10/previously-attending-companies.png)
2024 Partners:
![TR2048x878 TR2048x878](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2023/11/TR2048x878.png)
![MediNect MediNect](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2024/01/Untitled-design-35.png)
![OPTOMED_logo OPTOMED_logo](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2024/03/OPTOMED_logo.png)
Industry News:
“Great content from the most relevant players and very nice speakers from clinician and industry sides. Worth the time”
Senior Leader, Clinical Program, Ophthalmology, Clinical Development & Medical Affairs, Boehringer Ingelheim
![logo-iveric logo-iveric](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2023/11/logo-iveric.png)
Other Events in the Ophthalmology & Sensory Series:
![Brochure Brochure](https://wet-amd-drug-development.com/wp-content/uploads/sites/409/2024/03/Screenshot-71.png)
Download the 2024 Event Guide for More Information On:
- Expert Speaker Faculty
- Full 3-day Conference Agenda
- Audience Breakdown
- & more